144 related articles for article (PubMed ID: 38273052)
1. Investigation of Molecular Mechanisms of S-1, Docetaxel and Cisplatin in Gastric Cancer with a History of Helicobacter Pylori Infection.
Kashani SF; Abedini Z; Darehshouri AF; Jazi K; Bereimipour A; Malekraeisi MA; Javanshir HT; Mahmoodzadeh H; Hadjilooei F
Mol Biotechnol; 2024 May; 66(5):1303-1313. PubMed ID: 38273052
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori-induced miR-135b-5p promotes cisplatin resistance in gastric cancer.
Shao L; Chen Z; Soutto M; Zhu S; Lu H; Romero-Gallo J; Peek R; Zhang S; El-Rifai W
FASEB J; 2019 Jan; 33(1):264-274. PubMed ID: 29985646
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori infection is associated with favorable outcome in advanced gastric cancer patients treated with S-1 adjuvant chemotherapy.
Nishizuka SS; Tamura G; Nakatochi M; Fukushima N; Ohmori Y; Sumida C; Iwaya T; Takahashi T; Koeda K;
J Surg Oncol; 2018 Apr; 117(5):947-956. PubMed ID: 29355977
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Integration of Genome-Wide Association and Gene Expression Studies Reveals Novel Gene Signatures and Potential Therapeutic Targets for
Badr MT; Omar M; Häcker G
Front Immunol; 2021; 12():624117. PubMed ID: 33717131
[No Abstract] [Full Text] [Related]
5. Response Predictors of S-1, Cisplatin, and Docetaxel Combination Chemotherapy for Metastatic Gastric Cancer: Microarray Analysis of Whole Human Genes.
Kitamura S; Tanahashi T; Aoyagi E; Nakagawa T; Okamoto K; Kimura T; Miyamoto H; Mitsui Y; Rokutan K; Muguruma N; Takayama T
Oncology; 2017; 93(2):127-135. PubMed ID: 28511180
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling in human gastric mucosa infected with Helicobacter pylori.
Hofman VJ; Moreilhon C; Brest PD; Lassalle S; Le Brigand K; Sicard D; Raymond J; Lamarque D; Hébuterne XA; Mari B; Barbry PJ; Hofman PM
Mod Pathol; 2007 Sep; 20(9):974-89. PubMed ID: 17643099
[TBL] [Abstract][Full Text] [Related]
7. The novel ZEB1-upregulated protein PRTG induced by Helicobacter pylori infection promotes gastric carcinogenesis through the cGMP/PKG signaling pathway.
Xiang T; Yuan C; Guo X; Wang H; Cai Q; Xiang Y; Luo W; Liu G
Cell Death Dis; 2021 Feb; 12(2):150. PubMed ID: 33542225
[TBL] [Abstract][Full Text] [Related]
8. Status of kinases in Epstein-Barr virus and Helicobacter pylori Coinfection in gastric Cancer cells.
Sonkar C; Verma T; Chatterji D; Jain AK; Jha HC
BMC Cancer; 2020 Sep; 20(1):925. PubMed ID: 32993565
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori and Epstein-Barr Virus Coinfection Stimulates Aggressiveness in Gastric Cancer through the Regulation of Gankyrin.
Kashyap D; Baral B; Jakhmola S; Singh AK; Jha HC
mSphere; 2021 Oct; 6(5):e0075121. PubMed ID: 34585958
[TBL] [Abstract][Full Text] [Related]
10. Chemo-resistant Gastric Cancer Associated Gene Expression Signature: Bioinformatics Analysis Based on Gene Expression Omnibus.
Liu JB; Jian T; Yue C; Chen D; Chen W; Bao TT; Liu HX; Cao Y; Li WB; Yang Z; Hoffman RM; Yu C
Anticancer Res; 2019 Apr; 39(4):1689-1698. PubMed ID: 30952707
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori infection, gastrin and cyclooxygenase-2 in gastric carcinogenesis.
Shao Y; Sun K; Xu W; Li XL; Shen H; Sun WH
World J Gastroenterol; 2014 Sep; 20(36):12860-73. PubMed ID: 25278683
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation accumulation in gastric mucosa adjacent to cancer after Helicobacter pylori eradication.
Tahara S; Tahara T; Horiguchi N; Kato T; Shinkai Y; Yamashita H; Yamada H; Kawamura T; Terada T; Okubo M; Nagasaka M; Nakagawa Y; Shibata T; Yamada S; Urano M; Tsukamoto T; Kurahashi H; Kuroda M; Ohmiya N
Int J Cancer; 2019 Jan; 144(1):80-88. PubMed ID: 29978464
[TBL] [Abstract][Full Text] [Related]
13. The impact of Helicobacter pylori on EGF, EGF receptor, and the c-erb-B2 expression.
Jurkowska G; Piotrowska-Staworko G; Guzińska-Ustymowicz K; Kemona A; Świdnicka-Siergiejko A; Łaszewicz W; Dąbrowski A
Adv Med Sci; 2014 Sep; 59(2):221-6. PubMed ID: 25051417
[TBL] [Abstract][Full Text] [Related]
14. Molecular Pathogenesis of Helicobacter pylori-Related Gastric Cancer.
Shimizu T; Marusawa H; Watanabe N; Chiba T
Gastroenterol Clin North Am; 2015 Sep; 44(3):625-38. PubMed ID: 26314672
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori infection modulates the expression of miRNAs associated with DNA mismatch repair pathway.
Santos JC; Brianti MT; Almeida VR; Ortega MM; Fischer W; Haas R; Matheu A; Ribeiro ML
Mol Carcinog; 2017 Apr; 56(4):1372-1379. PubMed ID: 27862371
[TBL] [Abstract][Full Text] [Related]
16. Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model.
Zhang S; Lee DS; Morrissey R; Aponte-Pieras JR; Rogers AB; Moss SF
Cancer Lett; 2014 Dec; 355(1):106-12. PubMed ID: 25218349
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori infection affects the expression of PCNA, p53, c-erbB-2 and Bcl-2 in the human gastric mucosa.
Jorge O; Cuello Carrión FD; Jorge A; Ciocca DR
Rev Esp Enferm Dig; 2003 Feb; 95(2):97-104, 89-96. PubMed ID: 12760717
[TBL] [Abstract][Full Text] [Related]
18. Short-term results of a phase II study of preoperative docetaxel/cisplatin/S-1 therapy for locally advanced gastric cancer.
Tsuchida K; Sato T; Aoyama T; Atsumi Y; Kano K; Maezawa Y; Kazama K; Numata M; Yamada T; Tamagawa H; Murakami H; Oshima T; Saeki H; Cho H; Yukawa N; Yamamoto Y; Masuda M; Rino Y
Jpn J Clin Oncol; 2021 Mar; 51(3):371-378. PubMed ID: 33283236
[TBL] [Abstract][Full Text] [Related]
19. PRDX2 protects against oxidative stress induced by H. pylori and promotes resistance to cisplatin in gastric cancer.
Wang S; Chen Z; Zhu S; Lu H; Peng D; Soutto M; Naz H; Peek R; Xu H; Zaika A; Xu Z; El-Rifai W
Redox Biol; 2020 Jan; 28():101319. PubMed ID: 31536951
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Gene Expression of miRNA-106b-5p and
Pereira J; Santos M; Delabio R; Barbosa M; Smith M; Payão S; Rasmussen L
Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32260540
[No Abstract] [Full Text] [Related]
[Next] [New Search]
